Tesamorelin comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-12-03. Where a claim depends on a specific study, the study is described rather than over-claimed.
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH receptor agonist |
| Residue count | 44 amino acids | Matches human GHRH(1-44) length |
| N-terminal modification | trans-3-hexenoyl group | Confers resistance to dipeptidyl peptidase IV |
| Appearance | White to off-white powder | Typically supplied lyophilized in a sealed vial |
| Solubility class | Freely soluble in water | Hydrophilic peptide; polar solvent compatible |
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
===== Guyana ===== In February 2024, president Lula announced he would visit Guyana and meet president Irfaan Ali to discuss topics such as the Essequiba border dispute with Venezuela and a potential hydro-power energy sharing agreement between Guyana and Brazil. On 28 February, Lula spoke at a CARICOM summit in Georgetown in which he said he intends Brazil to resume having diplomatic missions in the Caribbean nations. Lula added Brazil was making a monetary contribution to the Caribbean Development Bank.
=== List of resources === PhosphoSitePlus – A database of comprehensive information and tools for the study of mammalian protein post-translational modification ProteomeScout – A database of proteins and post-translational modifications experimentally Human Protein Reference Database – A database for different modifications and understand different proteins, their class, and function/process related to disease causing proteins PROSITE – A database of Consensus patterns for many types of PTM's including sites RESID – A database consisting of a collection of annotations and structures for PTMs. iPTMnet– A database that integrates PTM information from several knowledgbases and text mining results. dbPTM – A database that shows different PTM's and information regarding their chemical components/structures and a frequency for amino acid modified site Uniprot has PTM information although that may be less comprehensive than in more specialized databases. The O-GlcNAc Database - A curated database for protein O-GlcNAcylation and referencing more than 14 000 protein entries and 10 000 O-GlcNAc sites.
In 1611 Johannes Kepler studied the packing of spheres, in order to explain the hexagonal symmetry of snow crystals. Kepler demonstrated that in a compact packing each sphere has six neighbours in the same plane, three in the plane above, and three in the plane below, for a total of twelve touching spheres. Kepler concluded that π/(3√2) = 0.74084 is the maximum possible density amongst any arrangement of spheres — this became known as the Kepler conjecture. The conjecture was finally proved by Thomas Hales in 1998. By the second half of the 17th century the ideas of Paracelsus had been displaced by a more scientific approach to chemistry, geology, mineralogy, and the emerging field of crystallography. In his book The Sceptical Chymist of 1661, Robert Boyle criticized the traditional composition of materials, as represented by the teaching of Aristotle and Paracelsus, and initiated the modern understanding of chemical elements using the words "perfectly unmingled bodies". Boyle argued that matter's basic elements consisted of various types of particles, termed "corpuscles", which were capable of arranging themselves into groups (molecules). Boyle was one of the earliest researchers to use the term crystal for crystalline substances apart from quartz. In 1665 Robert Hooke attempted to explain crystal morphology based on the stacking of atoms. In his work Micrographia he reported on the regularity of quartz crystals observed with the recently invented microscope, and proposed that they are formed by spherules.
Sources: en.wikipedia.org
=== Initial appearance === The first known documented instance of an attack by the Phylloxera in France was in the village of Pujaut in the department of Gard of the former province of Languedoc, in 1863. The wine makers there did not notice the aphids, just as the French colonists in America had not, but they noted the mysterious blight that was damaging their vines. The only description of the disease that was given by these wine growers was that it "reminded them distressingly of 'consumption'"(tuberculosis). The blight quickly spread throughout France, but it was several years before the cause of the disease was determined.
The Ministry of Justice confirms that serial killer Levi Bellfield, who is serving two whole life sentences for murder, will be allowed to marry his girlfriend in prison as there are no legal restrictions preventing him from doing so. Boris Johnson breaks the Ministerial Code for a second time, by not asking advice from the Advisory Committee on Business Appointments before accepting a new job writing for the Daily Mail. The previous time was shortly after he stood down as foreign secretary in July 2018, when he accepted a similar job with the Daily Telegraph. A 31-year-old man is charged with three counts of murder and three of attempted murder following the Nottingham attacks. 17 June David Warburton, the MP for Somerton and Frome, becomes the fourth Conservative MP in eight days to announce their resignation from the House of Commons, doing so following his suspension from the party over allegations of sexual misconduct, and triggering a by-election in his constituency. The 2023 Trooping the Colour ceremony takes place. 18 June – Partygate: The Mirror publishes video footage of a party held in December 2020 at Conservative Party Headquarters. Housing Secretary Michael Gove describes the incident as "indefensible". 19 June – Partygate: MPs back, by 354 votes to seven, a report finding Boris Johnson deliberately misled the Commons over lockdown parties at Downing Street. 20 June The Chancellor, Jeremy Hunt, rules out direct financial support for mortgage holders, over fears it would "make inflation worse, not better".
Hummingbirds resemble sunbirds. The former live in the Americas and belong to an order or superorder including the swifts, while the latter live in Africa and Asia and are a family in the order Passeriformes. Also the nectar-feeding Hawaiian honeycreepers resemble the two and differs from other honeycreeper. Flightlessness has evolved in many different birds independently. However, taking this to a greater extreme, the terror birds, Gastornithiformes and dromornithids (ironically all extinct) all evolved the similar body shape (flightlessness, long legs, long necks, big heads), yet none of them were closely related. They also share the trait of being giant, flightless birds with vestigial wings, long legs, and long necks with the ratites, although they are not related. Certain longclaws (Macronyx) and meadowlarks (Sturnella) have essentially the same striking plumage pattern. The former inhabit Africa and the latter the Americas, and they belong to different lineages of Passerida. While they are ecologically quite similar, no satisfying explanation exists for the convergent plumage; it is best explained by sheer chance. Resemblances between swifts and swallows is due to convergent evolution. The chimney swift was originally identified as chimney swallow (Hirundo pelagica) by Carl Linnaeus in 1758, before being moved to the swift genus Chaetura by James Francis Stephens in 1825.
Sources: en.wikipedia.org
The principal difference is a chemical cap on the N-terminal tyrosine that prevents rapid enzymatic cleavage. Native GHRH is degraded within minutes in plasma, whereas the modified peptide persists considerably longer. The amino acid backbone otherwise mirrors the natural hormone.
No. It is a receptor agonist that stimulates the pituitary to release endogenous growth hormone. It does not contain or deliver growth hormone. Its downstream effects therefore depend on a functioning pituitary and an intact signaling pathway.
Pituitary responsiveness, receptor availability, and the natural pulsatility of the growth hormone axis all contribute. Because the compound amplifies an existing release pattern rather than overriding it, timing and physiological state matter. Individual variability in response is well documented but not fully explained.
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.